Malignancies in sickle cell disease patients treated with hydroxyurea

Br J Haematol. 2003 Oct;123(2):368-9. doi: 10.1046/j.1365-2141.2003.04614.x.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Anemia, Sickle Cell / drug therapy*
  • Antisickling Agents / adverse effects*
  • Female
  • Humans
  • Hydroxyurea / adverse effects*
  • Leukemia, Promyelocytic, Acute / chemically induced*

Substances

  • Antisickling Agents
  • Hydroxyurea